In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), of whom 17.1 million did not know they were infected. Whilst the number of new human immunodeficiency virus (HIV) infections has declined globally since 2000, there are still regions where new infection rates are rising, and diagnosing HIV early in the course of infection remains a challenge. Late presentation to care in HIV refers to individuals newly presenting for HIV care with a CD4 count below 350 cells/µl or with an acquired immune deficiency syndrome (AIDS)-defining event. Late presentation is associated with increased patient morbidity and mortality, healthcare costs and risk of onward transmission by individuals unaware of their statu...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
Objectives: To determine the frequency of missed opportunities (MOs) among patients newly-diagnosed ...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
INTRODUCTION: Late presentation to HIV care leads to increased morbidity and mortality. We explored ...
Introduction: Late presentation to HIV care leads to increased morbidity and mortality. We explored ...
To determine the frequency of missed opportunities (MOs) among patients newly diagnosed with HIV, ri...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
A substantial proportion of HIV-infected individuals do not present for HIV testing until late in in...
QUESTIONS UNDER STUDY:We sought to identify reasons for late human immunodeficiency virus (HIV) test...
Late diagnosis of HIV results in increased morbidity and mortality and raises the potential for onwa...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
Objectives: To determine the frequency of missed opportunities (MOs) among patients newly-diagnosed ...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
INTRODUCTION: Late presentation to HIV care leads to increased morbidity and mortality. We explored ...
Introduction: Late presentation to HIV care leads to increased morbidity and mortality. We explored ...
To determine the frequency of missed opportunities (MOs) among patients newly diagnosed with HIV, ri...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
A substantial proportion of HIV-infected individuals do not present for HIV testing until late in in...
QUESTIONS UNDER STUDY:We sought to identify reasons for late human immunodeficiency virus (HIV) test...
Late diagnosis of HIV results in increased morbidity and mortality and raises the potential for onwa...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Late presentation (LP) for HIV care across Europe remains a significant issue. We provide a cross-Eu...
Objectives: To determine the frequency of missed opportunities (MOs) among patients newly-diagnosed ...